| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/12/2008 | CN100374161C Triacetin as a transdermal penetration enhancer |
| 03/12/2008 | CN100374160C Anti-cancer medicine composition containing antimetabolite |
| 03/12/2008 | CN100374158C application of agent for lowering the cell ATP level in preparing medicine |
| 03/12/2008 | CN100374156C Health products for face care and body care |
| 03/12/2008 | CN100374155C Use of insulin promoting peptide and nutrient, parenteral nutrition composition and pharmaceuticals |
| 03/12/2008 | CN100374143C Gastrodia freeze dried powder injection for intravenous injection and its preparation technology |
| 03/12/2008 | CN100374132C Compound Chinese and Western medicine prepn for treating women's climacteric syndrome and its prepn |
| 03/12/2008 | CN100374126C Capsule for treating myocardial strain, angina pectoris and arteriosclerosis and its preparing method |
| 03/12/2008 | CN100374125C Pharmaceutical compsn. contg. extract from barleria prionitis linn and its process of prepn |
| 03/12/2008 | CN100374122C Calf serum deprotein oral cavity ointment and its preparation method |
| 03/12/2008 | CN100374121C Tillering onion extract and its application |
| 03/12/2008 | CN100374120C Powder of flenabane and its preparation method as well as application in making drugs |
| 03/12/2008 | CN100374119C Pseudo-ginseng saponin oral disintegration tablet and preparing method |
| 03/12/2008 | CN100374118C Drip pill agent containing adefovir divoxil and its preparing method |
| 03/12/2008 | CN100374117C Weiding ointment and its prepn. process |
| 03/12/2008 | CN100374116C Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy |
| 03/12/2008 | CN100374115C Substituted diketopiperazines as oxytocin antagonists |
| 03/12/2008 | CN100374114C Antibiotic compositions for treatment of the eye, ear and nose |
| 03/12/2008 | CN100374113C Hypotensor composition |
| 03/12/2008 | CN100374112C Intranasal formulation of rotigotine |
| 03/12/2008 | CN100374111C Composition for preventing or treating allergic disease using black rice extract and its therapeutic use |
| 03/12/2008 | CN100374110C Local preparation containing poloxamer and other microbe killing agent and applicator |
| 03/12/2008 | CN100374109C Composition based on etyl ester of linoleic acid and triethyl ester of citric acid for topical use in the treatment of seborrhea and acne |
| 03/12/2008 | CN100374108C Compositions for promoting sleep |
| 03/12/2008 | CN100374107C Preparation of honokiol, magnolol or their admixture and usage in preparing medication for treating cardiovascular and cerebrovascular diseases |
| 03/12/2008 | CN100374106C High nurity elemene anti-cancer medicine and its preparing method |
| 03/12/2008 | CN100374104C Scutellaria alkyl amine granules and its preparation method |
| 03/12/2008 | CN100374099C Antimicrobial composition |
| 03/12/2008 | CN100374044C Primary composition containing lipophilic bioactive compound |
| 03/12/2008 | CN100374041C Solid preparation with multi-core texture |
| 03/11/2008 | US7342137 4-hydroxy-2,3 -dimethoxy-6-methyl-5(3,7,11-trimethyl-dodeca-2,6,10-trienyl)-cyclohex-2-enone; camphor chamber mushroom extract; anticarcinogenic, antitumor agent; breast, prostate, hepatic cancer; antioxidant |
| 03/11/2008 | US7342133 [2-(4-chlorobenzyl)-cyclohept-1-enylmethyl]-dimethylamine hydrochloride; serotonin (5-HT), noradrenaline (NA) inhibitors; antidepressant, anxiolytic agent; analgesic; cognition activator; side effect reduction; coupling beta-aminoketones with Grignard reagents, dehydroxilation with (in)organic acid |
| 03/11/2008 | US7342132 Formoterol tartrate process and polymorph |
| 03/11/2008 | US7342131 Levodopa prodrugs, and compositions and uses thereof |
| 03/11/2008 | US7342127 Substituted anilide ligands for the thyroid receptor |
| 03/11/2008 | US7342125 Administering derivatives of Kauranoic acid; cachexia, analgesics, in treating immune disorders, as anti-cancer and anti-tumor agents, otitis media, sinusitis, antidiabetic agent |
| 03/11/2008 | US7342122 Platinum or Palladium as a metal; soft tissues surrounding bone and bone-related diseases: bone cancer and osteoporosis; chemotherapy; inhibition of DNA synthesis, growth arrest in G2 phase of the cell cycle and undergo apoptosis; cytostatic and/or cytotoxic agents |
| 03/11/2008 | US7342120 Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 03/11/2008 | US7342118 Imidazole compounds for the treatment of neurodegenerative disorders |
| 03/11/2008 | US7342100 Hpr6 mutants and uses thereof |
| 03/11/2008 | US7342048 Bioabsorbable pharmaceutical formulation |
| 03/11/2008 | US7342046 co-crystal with acetic acid that inhibit the function(s) of anti-apoptotic Bcl-2 family proteins will kill cancer cells or supporting cells outright and/or render such cells as a population more susceptible; kits; instructions |
| 03/11/2008 | US7342045 Stabilized ascorbic acid solutions; use thereof; process for their obtention; and formulations comprising the same |
| 03/11/2008 | US7342044 Such as benzethonium chloride, and/or a polymeric quaternary ammonium biocide, with a ketone acid or salt (e.g. sodium dehydroacetate), and/or an aromatic carboxylic acid or salt; use in cosmetics, household, industrial products |
| 03/11/2008 | US7342043 Medicinal compositions improving brain function and method for improving brain function |
| 03/11/2008 | US7342042 Lily of the valley aromachemicals |
| 03/11/2008 | US7342041 viricide; synergistic mixture with antiviral agent (ribavirin) and alpha - or pegylated interferon; Human Immunogeficiency Virus, Acquired Immune Deficiency Syndrome |
| 03/11/2008 | US7342040 5-fluorooxindole-3-carboxylic acid ester |
| 03/11/2008 | US7342039 Substituted indole oximes |
| 03/11/2008 | US7342038 Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment or prevention of diseases characterized by abnormal cell proliferation |
| 03/11/2008 | US7342037 Anti-inflammatory medicaments |
| 03/11/2008 | US7342035 Process for preparing zolmitriptan compounds |
| 03/11/2008 | US7342034 Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 03/11/2008 | US7342033 Use of riluzole for the treatment of multiple sclerosis |
| 03/11/2008 | US7342032 Psychiatric and neurological disorders; cannabinoid (cb1) receptor; such as 4-(4-Chlorophenyl)-5-(2,4-dichlorophenyl)-N-(1-piperidinyl)thiazole-2-carboxamide |
| 03/11/2008 | US7342030 Indole derivatives |
| 03/11/2008 | US7342029 Substituted indoles |
| 03/11/2008 | US7342028 Medical use for tachykinin antagonists |
| 03/11/2008 | US7342027 1-phenylpiperidin-3-one derivatives and processes for the preparation thereof |
| 03/11/2008 | US7342026 combining substituted quinolines with a carrier; leishmania/HIV infection; viricide, parasiticide |
| 03/11/2008 | US7342025 Substituted C-imidazo[1,2-a]pyridin-3-yl-methylamines |
| 03/11/2008 | US7342024 4-Oxo-1-3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors |
| 03/11/2008 | US7342022 Compounds in the treatment of dementia related diseases, Alzheimer's Disease and conditions associated with glycogen synthase kinase-3 |
| 03/11/2008 | US7342021 Phosphodiesterase 4 inhibitors |
| 03/11/2008 | US7342020 Effective against MMP 9 and 13; arthritis, atherosclerosis; synthesis |
| 03/11/2008 | US7342019 5, 6-diaryl-pyrazine-2-amide derivatives as CB1 antagonists |
| 03/11/2008 | US7342018 Urokinase inhibitors and uses thereof |
| 03/11/2008 | US7342017 Vanilloid Receptor 1 and metabotropic glutamate receptor 1 inhibitors; inhibition of capsaicin-induced or PH-induced activation of vanilloid receptors; antidepressant; anxiolytic agent; analgesics; addictive disorders; antiemetic agent |
| 03/11/2008 | US7342016 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives; use in combination with antineoplastic agents such as cisplatin |
| 03/11/2008 | US7342015 Indole derivatives |
| 03/11/2008 | US7342014 Diamine derivatives |
| 03/11/2008 | US7342013 Benzamides and related inhibitors of factor Xa |
| 03/11/2008 | US7342012 Inhibitors of αLβ2 mediated cell adhesion |
| 03/11/2008 | US7342011 Rifamycin analogs and uses thereof |
| 03/11/2008 | US7342010 2-thiaquinolizidines and process for the preparation thereof |
| 03/11/2008 | US7342009 Cyclic sulfonamides for inhibition of gamma-secretase |
| 03/11/2008 | US7342008 Containing a benzodiazepine ring; 2-Cyclopentylmethyl-3(S)-hydroxyl-1-oxo-5-phenylpentyl)amino-1-methyl-5-(4-fluoro-phenyl)-2,3-dihydro-1H-1,5-benzodiazepin-2-one; Alzheimer's disease and Down's Syndrome; prevent the formation of neurological deposits of amyloid protein |
| 03/11/2008 | US7342007 prevent the formation of neurological deposits of amyloid protein; Alzheimer's disease, cognitive impairment; novel lactarns; N2-[(3,5-difluorophenyl)acetyl]-N1-[(3S,7S)-1-methyl-2-oxo-7-phenyl-2,3,4,7-tetrahydro-1H-azepin-3-yl]-L-alaninamide; secretase inhibitors |
| 03/11/2008 | US7342006 Substituted 8-heteroaryl xanthines |
| 03/11/2008 | US7342005 2-(2-(3-carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1-hydroxyethyl)-1-methylcarbapenem-3-carboxylic acid; carbapenems derivatives containing a carboxy substituted phenyl group; broad spectrum antibacterial activity; good stability; beta-lactamases inhibitors; favourable duration of action; infections |
| 03/11/2008 | US7342004 Superoxide dismutase inhibitors |
| 03/11/2008 | US7342003 Synthesis of 2-aralkyloxyadenosines, 2-alkoxyadenosines, and their analogs |
| 03/11/2008 | US7342002 Expression vector comprising nucleotide sequences coding calreticulin/heat shock protein fusion for use as tool in enhancement and induction of major histocompatibility complex immunological response; immunotherapy; tissue targeted therapy |
| 03/11/2008 | US7342000 Semisynthetic macrolide antibiotics of the azalide series |
| 03/11/2008 | US7341993 Cross-linked glycopeptide—cephalosporin antibiotics |
| 03/11/2008 | US7341990 Methods and uses of leukotriene B4 hydroxylases to treat diseases |
| 03/11/2008 | US7341988 Method of treating influenza with geranyl-geranyl acetone |
| 03/11/2008 | US7341981 Spray composition having a deposition control agent |
| 03/11/2008 | US7341871 Recombinant expression vector comprising promoter sequence, age regulatory sequence; can use in treatment of age-related and liver diseases; operably linking nucleic acid sequence, promoter sequence, and age regulatory sequences to produce a transgene, introducing into cell |
| 03/11/2008 | US7341749 Administering mixture of flavopereirine and alstonine for preventing prostate cancer and/or reducing PSA levels and/or alleviating the symptoms of BPH (Benign Prostatic Hyperplasia) or PIN (prostatic intraepithelial neoplasia) |
| 03/11/2008 | US7341744 Administering aqueous soluble proanthocyanidin polymer isolated from a Croton species or a Calophyllum species; protective coating for oral administration |
| 03/11/2008 | US7341742 Simethicone containing tablet composition and method |
| 03/11/2008 | US7341741 Using polysaccharide selected from the group consisting of xanthan gum and hydroxypropylmethylcellulose (HPMC) for therapy and prophylaxis of Crohn's Disease, left-sided ulcerative colitis or pouchitis. |
| 03/11/2008 | US7341739 Small particle liposome aerosols for delivery of anti-cancer drugs |
| 03/11/2008 | US7341738 Lipid-encapsulated polyanionic nucleic acid |
| 03/11/2008 | US7341733 Pertussis toxin and analogs exhibit an adenosine-5* diphosphate-ribosyltransferase activity, useful in promoting prophylactic and/or therapeutic responses against another target antigen in a mammal patient |
| 03/11/2008 | US7341723 Nucleic acid construct encoding a processing component derived from the N-terminal region of the hepatitis virus ORF2, and an antigenic polypeptide |
| 03/11/2008 | US7341721 Agent that interacts with MHC beta2-microglobulin HLA class 1 molecules located on the tumor cell surface |
| 03/11/2008 | US7341717 Therapeutic targets for treatment of HCV infections, methods of treating HCV infections and compounds useful therefor |
| 03/11/2008 | US7341716 Solidifying mass in an ionic fluid- containing bodily cavity using polymer comprising 2-cyanoacrylate monomer |